Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response. - Wikidata - awgldk - TriplyDB

Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response.

Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response.

http://www.wikidata.org/entity/Q42227086

about

DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation The germinal center antibody response in health and disease Contribution of Toll-like receptor signaling to germinal center antibody responses Molecular programming of B cell memory B cells take the front seat: dysregulated B cell signals orchestrate loss of tolerance and autoantibody production IgH chain class switch recombination: mechanism and regulation Messenger RNA-based vaccines: progress, challenges, applications Control of adaptive immunity by the innate immune system Mechanisms of autoantibody production in systemic lupus erythematosus Allergen-specific immunotherapy: is it vaccination against toxins after all?TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice.Toll-like receptor ligands sensitize B-cell receptor signalling by reducing actin-dependent spatial confinement of the receptor.Monocyte-derived dendritic cells promote T follicular helper cell differentiation.TLR4 signals in B lymphocytes are transduced via the B cell antigen receptor and SYK.Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo.Pathogenetic importance and therapeutic implications of NF-κB in lymphoid malignancies.B cell TLRs and induction of immunoglobulin class-switch DNA recombination.Requirement for MyD88 signaling in B cells and dendritic cells for germinal center anti-nuclear antibody production in Lyn-deficient mice Altered B cell signalling in autoimmunity.Toll-like receptor 9 signaling acts on multiple elements of the germinal center to enhance antibody responses.Toll-like receptor 7 controls the anti-retroviral germinal center response Poke weed mitogen requires Toll-like receptor ligands for proliferative activity in human and murine B lymphocytes.Microbe-dependent CD11b+ IgA+ plasma cells mediate robust early-phase intestinal IgA responses in mice.B cell-intrinsic TLR7 signaling is essential for the development of spontaneous germinal centers.Early activation of teleost B cells in response to rhabdovirus infection.Bacterially produced recombinant influenza vaccines based on virus-like particles.Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody.Unique Roles of TLR9- and MyD88-Dependent and -Independent Pathways in Adaptive Immune Responses to AAV-Mediated Gene Transfer Liver fibrosis occurs through dysregulation of MyD88-dependent innate B-cell activity.Animal Models of Interferon Signature Positive Lupus.Breakdown in peripheral tolerance in type 1 diabetes in mice and humans B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage.Differential roles for RIG-I-like receptors and nucleic acid-sensing TLR pathways in controlling a chronic viral infection.TLR9 and MyD88 are crucial for the development of protective immunity to malaria.Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions MyD88 signaling in B cells regulates the production of Th1-dependent antibodies to AAV Maintenance of autoantibody production in pristane-induced murine lupus.Parasite-induced TH1 cells and intestinal dysbiosis cooperate in IFN-γ-dependent elimination of Paneth cells Beyond antigens and adjuvants: formulating future vaccines.Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus

P2860

Q24321675-013300F6-C455-4C13-BDF8-564F04B6C329 Q26745929-2E131E3D-8546-4110-A2BF-DC7B05F4AF19 Q26829061-E377683A-F934-4F0A-B120-A2551B9B7E40 Q26829944-CF34415E-7EB3-4118-AFB5-D8BCB5FCBD4D Q26996644-6A57C9B5-CBED-4885-B857-5876DB8E9C82 Q27001131-09831DA7-531E-4DE7-A3E7-FC2294F132D0 Q27012738-A8F32161-F40D-428D-A7D8-B714CDBF7422 Q27026513-A58930F4-D113-4DBB-B8E9-079001762BFC Q28082507-B35678D5-CEC8-458C-9D77-4E5D8055F11C Q30248317-45283311-4F9C-4ECA-AFBA-A82391DF1F55 Q30419734-7E8B6CEC-D099-4666-AFAD-35560FBEE085 Q30620402-32AF3C78-3F1A-437D-9734-2BD41B86CFB5 Q33623351-A22B6766-42B7-40CB-A7EA-FF446761E10B Q33627391-F994A9DA-A469-41EE-BDFF-054AEF7B2A29 Q33853324-A05451A6-5CF3-494F-865A-1849D4724200 Q33889168-7004C54F-7897-4A34-9811-03666C2FCB53 Q33893517-A6EEAE28-2774-40D1-A2BF-F06C483D49E0 Q33911256-8E50897B-26A2-4D15-A9F9-CE1FB79A6AA7 Q33924642-79EBCC81-B81B-4E11-843A-F3DFC8A9CC2B Q34025386-B8C2D2DA-DD69-49CA-BDC2-E2AD5D90A902 Q34048099-EB50450C-01B8-4E03-8444-70AEC647A576 Q34125267-A45EDAF3-C04E-4E75-B0F9-6E03C56FF826 Q34340937-45C294B8-183F-4626-93B2-EE7BE688953B Q34364711-3C54B8C8-8959-434F-8668-A86A2C81FC8D Q34991458-52CD9E18-F36D-4899-BABA-A8346D9B5FE8 Q35048127-311DFECE-A030-4A7A-90B5-E05BA5E7A910 Q35096289-E534015D-F307-4FD1-BAEF-5C98FA36CA37 Q35561776-28E102B4-A0A3-4B57-BCF9-E7626365AD27 Q35637517-8914B613-1850-4E1C-B0E5-07DDA3D7A22F Q35686914-06EC5F23-D6EF-4F20-B54D-5EA55E6C6068 Q35765731-8DAB3ECF-0388-4B0D-A2FC-BEE6E8230F9A Q35784554-174FAB60-1D95-4432-B376-DD8DCE87E93B Q35903286-E579C91D-DA14-4D4E-B4B3-D15AEE7E8C9E Q35936144-974408B0-0C5B-49FF-B024-70C17BFC6E53 Q36060329-D04B4373-4878-41AC-BD6E-052EA7A1CB83 Q36142477-FB739577-0B00-4675-91C9-031932C59BDB Q36477439-5DE4D031-6561-4DC1-9FAA-9CA7B1D682BF Q36553535-084D886B-3D6A-43DF-B5E3-D528E3EAC0A3 Q36618500-CB3ECBBC-89EE-487D-984B-3AD482A54973 Q36800112-852A1E7C-6DB0-4006-A185-A9555D44E288

P2860

Selective utilization of Toll-like receptor and MyD88 signaling in B cells for enhancement of the antiviral germinal center response.

http://www.wikidata.org/entity/Q42227086

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Selective utilization of Toll- ...... iral germinal center response.

@en

Selective utilization of Toll- ...... iral germinal center response.

@nl

type

label

Selective utilization of Toll- ...... iral germinal center response.

@en

Selective utilization of Toll- ...... iral germinal center response.

@nl

prefLabel

Selective utilization of Toll- ...... iral germinal center response.

@en

Selective utilization of Toll- ...... iral germinal center response.

@nl

P1433

Q42227086-6D2BF302-510A-4DFF-BD9C-886BA4BD6008

P1476

Q42227086-85656C57-C5A7-438A-A357-66605F475676

P2093

Q42227086-257317A3-4BA9-4E6C-B786-63BDE4B64276

Q42227086-52BB1E1C-C3EF-4C76-8E99-388CB190CD95

Q42227086-59FE2D0F-5BB7-44B9-B1CC-A35714297D43

Q42227086-7FF0E9B1-0BAB-42B2-845D-40B326A43EE9

Q42227086-CEAD2937-649D-4904-A61E-F4FFF3DDABC1

Q42227086-CFB6F2B8-92FF-4AC1-8AC6-2B961C75F75A

Q42227086-D60042EF-A3FA-42BB-B219-1BE2E16BA967

Q42227086-F367E23F-87F2-490A-A490-97BA3EC4E22D

Q42227086-FE61DBE4-95A8-4DA6-9933-2CB6F2077A47

P2860

Q42227086-15732618-0FEA-4F5C-8C00-2AA257621169

Q42227086-1E5C157F-0E97-4C81-8A41-394815796FAD

Q42227086-1FDF5905-F894-4774-B425-6B382E260908

Q42227086-221C9CC2-7369-4E5B-8B96-349119FF61C2

Q42227086-22258F37-6488-4EC1-B21A-66254A281677

Q42227086-2455097B-9E41-48EF-9C06-227E85E28252

Q42227086-29ACF0E4-7B5D-4F40-98D5-72094BD11E87

Q42227086-323B14CD-B3E4-4EB4-8080-6009FCACE6CE

Q42227086-38588E96-2AB4-49D8-9FC1-47FBB422CE4A

Q42227086-3F270864-1C85-4FFD-B366-2D81F449D029

P304

Q42227086-32E403D1-1BD7-43E0-BB6C-00A8D970D7FF

P31

Q42227086-035D620C-340C-4307-915C-517140896546

P356

Q42227086-A6A39942-069D-4822-B1FB-5C8BA2D0FE1D

P407

Q42227086-83A0C519-590D-4A09-88CC-32BB49433D9B

P433

Q42227086-988D88AE-6C31-44F9-8495-1CE946F51C7B

P478

Q42227086-6BC7F4B2-705A-417A-AB98-3324369770B6

P50

Q42227086-F88C3CF7-5543-4236-9940-6462DC18478C

P577

Q42227086-ED9DE889-D794-4C74-A17B-A894C9D15446

P5875

Q42227086-6A64B3DD-580C-4542-AA8B-1F94B95DCBC5

P698

Q42227086-36FF4C1B-84A6-4D91-B2A0-C2CC576D033C

P921

Q42227086-8AF744C0-6F9D-4A08-9F9A-3928B44B2565

P932

Q42227086-31AC17FF-D478-4128-9B41-516AAF980398

P356

J.IMMUNI.2011.01.011

P1433

P1476

Selective utilization of Toll- ...... iral germinal center response.

@en

P2093

Anthony L DeFranco

http://www.w3.org/2001/XMLSchema#string

Gary Ott

http://www.w3.org/2001/XMLSchema#string

Lili Kuzmich

http://www.w3.org/2001/XMLSchema#string

Linda M Lee

http://www.w3.org/2001/XMLSchema#string

Martin F Bachmann

http://www.w3.org/2001/XMLSchema#string

Matthew L Wheeler

http://www.w3.org/2001/XMLSchema#string

Ming Ji

http://www.w3.org/2001/XMLSchema#string

Philippe Saudan

http://www.w3.org/2001/XMLSchema#string

Robert L Coffman

http://www.w3.org/2001/XMLSchema#string

P2860

Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

In vivo depletion of CD11c+ dendritic cells abrogates priming of CD8+ T cells by exogenous cell-associated antigens

Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling.

Endocytic sequestration of the B cell antigen receptor and toll-like receptor 9 in anergic cells.

Both innate immunity and type 1 humoral immunity to Streptococcus pneumoniae are mediated by MyD88 but differ in their relative levels of dependence on toll-like receptor 2.

Toll-like receptors activate innate and adaptive immunity by using dendritic cell-intrinsic and -extrinsic mechanisms

T cell-independent antigens type 2.

Neutralizing antiviral antibody responses.

P304

375-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.IMMUNI.2011.01.011

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

34

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-02-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50213383

http://www.w3.org/2001/XMLSchema#string

P698

21353603

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor

P932

3064721

http://www.w3.org/2001/XMLSchema#string